Authors' reply to the Letters to the Editor discussing main outcomes of the PRODIGE 23 study
Ann Oncol
.
2024 Oct 12:S0923-7534(24)04056-0.
doi: 10.1016/j.annonc.2024.10.007.
Online ahead of print.
Authors
T Conroy
1
,
S Gourgou
2
,
C Borg
3
Affiliations
1
Institut de Cancérologie de Lorraine and INSERM INSPIIRE, Université de Lorraine, Nancy, France. Electronic address: t.conroy@nancy.unicancer.fr.
2
Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
3
University Hospital of Besançon, Besançon, France.
PMID:
39401548
DOI:
10.1016/j.annonc.2024.10.007
No abstract available
Publication types
Letter